Direct Acting Antivirals in Hepatitis C-Infected Kidney Transplant Recipients: Associations with Long-term Graft Failure and Patient Mortality

Direct Acting Antivirals in Hepatitis C-Infected Kidney Transplant Recipients: Associations with Long-term Graft Failure and Patient Mortality

Background: Direct-acting antiviral (DAA) therapy among hepatitis C virus (HCV)-infected kidney transplant recipients is associated with short-term improvement in protein/creatinine (P/C) ratios, but how HCV cure affects long-term graft outcomes remains unknown. Methods: This is a retrospective fol...

Full description

Bibliographic Details
Main Authors: Michael R Goetsch, Ashutosh Tamhane, Edgar T Overton, Graham C Towns, Ricardo A Franco
Format: Article
Language:English
Published: Case Western Reserve University 2020-09-01
Series:Pathogens and Immunity
Subjects:
direct-acting antivirals
kidney transplant
hepatitis c virus
proteinuria
mortality
graft failure
outcomes
Online Access:https://paijournal.com/index.php/paijournal/article/view/369

Similar Items

Similar Items